Also, data in The Human Protein Atlas showed that KIAA0930 expression significantly affects survival in patients with carcinomas (https://www.proteinatlas.org/ENSG00000100364-KIAA0930/pathology), such as liver, renal or endometrial cancer, which also supports a role of KIAA0930 as a carcinoma-associated candidate gene. This evidence concerns the gene KIAA0930 and endometrial cancer.